Alendronate Sodium-Impurities | Pharmaffiliates

alendronate sodium

Alendronic acid was first described in 1978 and approved for medical use in the United States in 1995. It is available as a generic medication. Reference standards of Alendronate Sodium API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Alendronate Sodium (1012780)
    [catalogue_number] => PA USP1012780
    [category_ids] => ,149,
    [chemical_name] => 
    [weight] => NA
    [form] => NA
    [cas] => 121268-17-5
    [pslug] => 121268-17-5-alendronate-sodium-1012780-pausp1012780
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)

Alendronate Sodium (1012780)


  • Catalogue No.:PA USP1012780

  • CAS :

    121268-17-5

  • Molecular Formula : NA

  • Molecular Weight : NA